Action NTRA NATERA, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Natera, Inc.

Actions

NTRA

US6323071042

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 14/05/2024 		Varia. 5j. Varia. 1 janv.
105,5 USD +2,12 % Graphique intraday de Natera, Inc. +8,62 % +68,45 %
14/05 NATERA, INC. : Piper Sandler favorable sur le dossier ZM
13/05 NATERA, INC. : BTIG maintient sa recommandation à l'achat ZM

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Natera Insider Sold Shares Worth $3,137,567, According to a Recent SEC Filing
Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall, 5/10/2024
Top Premarket Gainers
Natera Q1 Loss Narrows, Revenue Rises; Full-Year Revenue Guidance Raised -- Shares Jump After Hours
Natera: Q1 Earnings Snapshot
Natera : Q1 2024 Earnings Presentation
Natera, Inc. Provides Earnings Guidance for the Year 2024
Earnings Flash (NTRA) NATERA Reports Q1 Revenue $367.7M, vs. Street Est of $315.3M
Natera, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Natera Reports First Quarter 2024 Financial Results
New Natera Publication Bolsters Evidence for Extended Surveillance with Signatera in Breast Cancer
New Natera Publication Bolsters Evidence for Extended Surveillance with Signatera™ in Breast Cancer
Natera, Inc. Announces a New Publication in JCO Precision Oncology Reporting on the Ability of its Personalised and Tumor-Informed Molecular Residual Disease Test, Signatera
Natera to Report its First Quarter 2024 Results on May 9
Natera Launches Fetal RhD NIPT Supporting Ob/Gyn Physicians and Patients During RhIg Shortage
Natera, Inc. Launches Fetal RhD NIPT Supporting Ob/Gyn Physicians and Patients During RhIg Shortage
Natera Announces Significant Milestone with 200+ Peer-Reviewed Publications
Natera Insider Sold Shares Worth $7,265,651, According to a Recent SEC Filing
Natera Insider Sold Shares Worth $634,797, According to a Recent SEC Filing
Natera Announces Publication of Largest Prospective dd-cfDNA Study in Kidney Transplantation
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action NTRA
  4. Actualités Natera, Inc.
  5. Autres langues